Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples